Shin-Ichi Miyatake
Overview
Explore the profile of Shin-Ichi Miyatake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
1890
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawabata S, Kashiwagi H, Nonoguchi N, Furuse M, Takami T, Miyatake S, et al.
No Shinkei Geka
. 2024 Jul;
52(4):782-793.
PMID: 39034516
The debate regarding the role and clinical impact of radiotherapy for meningiomas remains underdeveloped due to insufficient evidence. However, following recent revisions in the WHO classification and the integration of...
2.
Kayama R, Tsujino K, Kawabata S, Fujikawa Y, Kashiwagi H, Fukuo Y, et al.
Sci Rep
. 2024 Apr;
14(1):8265.
PMID: 38594281
Boron neutron capture therapy (BNCT) is a type of targeted particle radiation therapy with potential applications at the cellular level. Spinal cord gliomas (SCGs) present a substantial challenge owing to...
3.
Takagi F, Furuse M, Kuwabara H, Kambara A, Omura N, Tanabe S, et al.
Neuropathology
. 2023 Dec;
44(3):240-246.
PMID: 38069461
We report the case of a 70-year-old woman with metastatic brain tumors who underwent surgical removal of the tumor and radiation necrosis. The patient had a history of colon cancer...
4.
Fujikawa Y, Fukuo Y, Nishimura K, Tsujino K, Kashiwagi H, Hiramatsu R, et al.
Biology (Basel)
. 2023 Sep;
12(9).
PMID: 37759639
High-grade gliomas present a significant challenge in neuro-oncology because of their aggressive nature and resistance to current therapies. Boron neutron capture therapy (BNCT) is a potential treatment method; however, the...
5.
Tsujino K, Kashiwagi H, Nishimura K, Kayama R, Yoshimura K, Fukuo Y, et al.
Biology (Basel)
. 2023 Mar;
12(3).
PMID: 36979069
Integrin αβ is more highly expressed in high-grade glioma cells than in normal tissues. In this study, a novel boron-10 carrier containing maleimide-functionalized -dodecaborate (MID), serum albumin as a drug...
6.
Kashiwagi H, Hattori Y, Kawabata S, Kayama R, Yoshimura K, Fukuo Y, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831378
Background: Boron neutron capture therapy (BNCT) has been adapted to high-grade gliomas (HG); however, some gliomas are refractory to BNCT using boronophenylalanine (BPA). In this study, the feasibility of BNCT...
7.
Sakai K, Ikeda N, Fukumura M, Omura N, Yagi R, Hiramatsu R, et al.
World Neurosurg
. 2023 Jan;
172:e524-e531.
PMID: 36702243
Objective: The objective of this study was to verify that spine surgery for late-stage elderly (LSE) (age 65-74 years) is as safe as that for early-stage elderly (ESE) (age 65-74 ...
8.
Kondo N, Sakurai Y, Takata T, Kano K, Kume K, Maeda M, et al.
Sci Rep
. 2022 May;
12(1):8718.
PMID: 35610277
Brain radiation necrosis (RN) or neurocognitive disorder is a severe adverse effect that may occur after radiation therapy for malignant brain tumors or head and neck cancers. RN accompanies inflammation...
9.
Takahara K, Miyatake S, Azuma H, Shiroki R
Int J Urol
. 2022 Mar;
29(7):610-616.
PMID: 35240726
Boron neutron capture therapy is based on a nuclear reaction between the nonradioactive isotope boron-10 and either low-energy thermal neutrons or high-energy epithermal neutrons, which generate high linear energy transfer...
10.
Furuse M, Kawabata S, Wanibuchi M, Shiba H, Takeuchi K, Kondo N, et al.
Jpn J Clin Oncol
. 2022 Jan;
52(5):433-440.
PMID: 35079791
Background: Although boron neutron capture therapy has shown excellent survival data, previous studies have shown an increase in radiation necrosis against recurrent malignant glioma. Herein, we proposed that bevacizumab may...